Carole Masurier
Evry, 91002, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Capsid-specific removal of circulating antibodies to adeno-associated virus vectors.
Journal: Scientific reports
Published: October 07, 2019
Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients.
Journal: Cellular immunology
Published: February 21, 2018
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
Journal: Nature communications
Published: August 18, 2016
Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 28, 2014
Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy.
Journal: Science translational medicine
Published: January 24, 2014
Humoral and cellular capsid-specific immune responses to adeno-associated virus type 1 in randomized healthy donors.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 18, 2012
A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.
Journal: Brain : a journal of neurology
Published: January 14, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026